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 Abstract - This paper investigates the depth of anaesthesia 
(DoA) control system using robust deadbeat technique. We 
propose to apply deadbeat control technique and develop a 
robust controller. The proposed robust control system with a 
deadbeat controller is evaluated in simulation. The performance 
is compared with that of a traditional control system with a PID 
controller and a control system with an internal model (IMC) 
controller. The results  show that the proposed scheme has about 
15% less overshoot, shorter settling time  (about 1.5 minutes 
shorter) and more robust  to disturbances caused by parameter 
changes. In addition, the proposed method is easy to design and 
impalement. 
 
 Index Terms – Deadbeat control. Depth of anaesthesia. 
 
I.  INTRODUCTION 
 More recently, considerable efforts have been made to 
identify and control systems with uncertainty and nonlinearity 
in medical related control system. Dwayne (1997)  developed 
a closed-loop PID controller to control the depth of anesthesia 
[1]. Sakai et al. (2000) employed a closed-loop PID control 
system for propofol administration using BIS (Bispectral 
Index) as the controlled variable.   Both of them concluded 
that their systems provided intra-operative hemodynamic 
stability and a prompt recovery from the sedative-hypnotic 
effects of propofol [2]. Absalom et al. (2002) developed a 
similar closed-loop PID controller using BIS as the controlled 
variable, and a propofol targeting central plasma 
concentration-controlled infusion system as the control 
actuator [3]. The authors concluded that further studies were 
required to determine if control performance could be 
improved by changing the proportional gains of the PID 
controller or by using an effect-site-targeted propofol 
controlled infusion system. Later, they modified their control 
algorithm to a target-controlled infusion (TCI) system which 
regulated effect-site concentration, and proved it to be more 
efficient.  However, the PID controller still faced some 
stability problems [4]. 
 
 This study applies the deadbeat robust control technique 
to the depth of anaesthesia. First, a DoA model is build up 
based on our literature review. This model is a single-input-
single-output (SISO) system with nonlinear component. Then, 
a PID-based robust deadbeat control scheme is applied to the 
SISO systems, and a deadbeat controller is designed. The 
robust deadbeat controller can tolerate system parameter’s 
uncertainty for up to ± 50% [5]. The additions of the extra 
gains allow and permit the designer more flexibility of making 
any plant work with this method. This feature is used to deal 
with the uncertainty of the DoA model. The proposed method 
is implemented and evaluated in simulation.   Comparing with 
other two different PID based control systems,  the proposed 
method has less over and undershoot, shorter settling time and 
more robust to parameter change caused  disturbances.  
 This paper is structured as follows. The DoA model is 
introduced in Mathematical Model of Anaesthesia section. 
The Deadbeat Control technique is explained in Method of 
Deadbeat Control for DoA section. The implementation and 
simulation study is providing in the Simulation and Results 
section. In this section we also analysed and compared the 
simulated results. Finally, the main findings of this paper are 
summarised in the Conclusion section.     
 
II. MATHEMATICAL MODEL FOR DEPTH OF ANAESTHESIA 
CONTROL 
 First we consider  the  drug  modeling approach and how  
the  administered  drug  distributes  within  the  body.  This 
step leads to a pharmacokinetic model (PK) which can be used 
to predict the blood plasma concentration of the drug [6]. The 
second step is the mathematical expression relate to 
concentration to the drug effect itself. This expression is 
referred to as pharmacodynamic model (PD) [7].                 
   
A. Pharmacokinetics 
 Pharmacokinetics is the study of the absorption, 
distribution, metabolism and elimination of drugs by the body 
as shown in Fig. 1. The pharmacokinetic  model of a drug is  a  
mathematical  term  relating  to the  drug  blood plasma  
concentration  C୮ ሺs)  to  the  administered  dose  uሺs).  The 
aim of this section is thus to define the transfer function of 
PKሺs): 
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Fig. 1 The pharmacokinetic model 
 
 The PK  can be expressed as  a  time  course  of  the  
concentration  of  any given  drug  within  the  plasma  and  
other  tissues  of the  human  body. Throughout  the  
absorption phase  following  an  intravenous  bolus  
administration,  the  anaesthetic (propofol)  mixes  quickly 
within  the  central  blood  pool, resulting  in  a  plasma  peak  
concentration [8]. There is a delay  elapses  between  the  
actual  injection of the  anaesthetic (propofol)  and  its  mixing  
within the  blood  pool.  Systemic  circulation then  distributes  
the  anaesthetic  to  a  variety  of  tissues  within  the  body [6]. 
The  time  course  of  the  concentration  for    most  drugs, 
within  the  blood  plasma  after  the  intravenous 
administration  and  uptake  can  be  fitted  to  resemble  a  
decaying  function,  with  two  distinct  modes  corresponding  
to  the  distribution  and  elimination  phase  respectively. This 
behavior can be expressed mathematically as: 
 
࡯࢖ሺ࢚) ൌ ࢄࢋି࡭࢚ ൅ ࢅࢋି࡮࢚                  ቀ
ࣆࢍ
࢓࢒ቁ                     ሺ૛) 
 
  where  C୮ሺt)  is  the  drug  plasma concentration  expressed  
in  microgram  per  milliliter  ( propofol), A  is the   rate  
constant  of the  distribution phase,  B  is  the  rate  constant  of 
the  elimination phase. 
In  many  cases,  a  tri-exponential  model  will  capture  the  
kinetic of the  drug much better [6].  
 
ܥ௣ሺݐ) ൌ ܺ݁ି஺௧ ൅ ܻ݁ି஻௧ ൅ ܼ݁ି஼௧     ቀ
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݈݉ቁ                               ሺ3) 
 
where Z and C to  describe  the   fast  dynamics  corresponding  
to  the   distribution  phase. 
 A   main  advantage  of  exponential  models  is  that  they  
can  be  simply  derived  using  graphical  means. The  
identification can  be  carried  out  directly by  using either  
bolus  data  or  analysing the  decaying blood  plasma  
characteristic,  or  by using  infusion data  and  analysing how  
the  plasma  concentration  increases  over  time [6]. 
 
 In   terms of control and system engineering, the 
exponential model in (3) can be directly expressed as: 
 
ܲܭሺݏ) ൌ ܥ௣ሺݏ)ݑሺݏ) ൌ
ܺ
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ݏ ൅ ܤ ൅
ܼ
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 The total amount of the anaesthetic delivered into 
compartment one ( Cଵ ) is eliminated according to the rate 
constant kଵ଴. The anaesthetic is distributed in the other two 
compartments ( Cଶ , Cଷ ) at a rate of kଵଶ  and kଵଷ . The 
concentration of Cଵ decreases quickly while the concentrations 
Cଶ , Cଷ increase. Once the concentrations in the compartment 
one and any of the peripheral compartments (Cଶ , Cଷ) attain 
and reach equilibrium, the distributive process setback and the 
anaesthetic stored in the peripheral compartment returns back 
to the central compartment at the rate of kଶଵ or kଷଵ. Because 
the blood of the compartment one acts as a transporter for the 
anaesthetic, that is mean there is no direct exchange between 
the two peripheral compartments. In other words, only the 
anaesthetic presents in the compartment one can be eliminated 
[7]. 
 The mathematical expressions in a state space 
representation can be obtained by writing the mass balance 
equations in (5): 
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where  Vଵ  is the  volume of  compartment one.   Also, by 
definition,  the  plasma blood concentration equals  the  drug  
concentration  of the compartment one,  i.e.,  C୮ሺt) ൌ Cଵሺt). 
 In  order  to  simplify  the PKሺs) model  as  a  SISO  
transfer   function using both  the  exponential and  
compartmental  parameters as in (6) [9]: 
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B. Pharmacodynamics 
 
 Pharmacodynamics (PD) is the study of the effects of 
drugs and the relationship between drug concentration and 
effect. The  function  of  the PD  model is  to  mathematically  
express  the  observed  effect  of  a  drug  as  a low-pass filter  
is  used  to  relate  the  propofol  plasma  concentration as 
shown in Fig. 2 [6]: 
 
ܲܦሺݏ) ൌ ܧሺݏ)ܥ௣ሺݏ                                                                                 ሺ7) 
 
where  PDሺs) is the  pharmacodynamic  model  and  Eሺs) is 
the  drug  effect. 
  
The  effect-site  concentration  is  related  to  DoA  as  (Hill 
equation) [10]. 
ܧሺݐ) ൌ ܧ଴ െ ܧ௠௔௫ .
ܥ௘ఊሺݐ)
ܥ௘ఊሺݐ) ൅ ܧܥହ଴ఊ
                                           ሺ8) 
 
 The mathematical express of the effect site drug 
concentration Cୣሺs)  as a function of the plasma concentration 
C୮ሺs) as in equation (9): 
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Fig. 2 The pharmacodynamic model 
 
III. DEADBEAT CONTROL FOR DOA 
 Fig. 3 shows the basic structure of the robust deadbeat 
control system, and Table I is   the deadbeat controller 
coefficients and response times. This technique is initially 
works only for lower-order plants [11].  If a higher–order plant 
systems considered, then there is a need for higher gain, 
therefore this design with a proper and accurate high gain 
result in systems that are intensive to plant parameters 
variation and uncertainties of up to 50% [5].  Changes in 
patient’s PK and PD parameters (kଵ଴, kଵଶ, kଵଷ,…….. ECହ଴, γ 
and  kୣ଴) form 10% to  20%, 30%, 40% up to 50% the robust 
deadbeat controller is still able to tolerate these  parameter  
changing. 
 The deadbeat controller design and derivation method 
utilizes the following procedures. Firstly using a PID 
controller as Gୡሺs), and then adding a cascade gain K before 
the PID controller. Add a state variable feedback gain Kୟ, that 
will make the system over specified by at least one variable. 
Determine the number of poles for GୡGሺs), where n୮  equals 
the number of poles in GୡGሺs).Refer to Fig. 3 the feedback 
H(s) it depends on the number of poles in GୡGሺs) ,and the 
following steps are involved with this method: 
 
1) ࡴሺ࢙) ൌ ૚ for ࢔࢖ ൌ ૛. 
2) ࡴሺ࢙) ൌ ૚ ൅ ࡷ࢈࢙ for  ࢔࢖ ൌ ૜ or 4. 
3) ࡴሺ࢙) ൌ ૚ ൅ ࡷ࢈࢙ ൅ ࡷࢉ࢙૛ for ࢔࢖ ൌ ૞. 
 And then select gains, using the coefficients from Table 1, 
to achieve the deadbeat response with the following 
requirements:  
4) Set ࡷ ൌ ૚. 
5) Set  ࣓࢔ ൌ ࢀ࢙
′
ሺૡ૙% ࢕ࢌ ࢚ࢎࢋ ࢊࢋ࢙࢏࢘ࢋࢊ ࢙ࢋ࢚࢚࢒࢏࢔ࢍ ࢚࢏࢓ࢋ) 
6) The characteristic equation of the closed loop 
transfer equation will equal to: 
 
࢙࢔࢖ ൅ ࢻ࣓࢔࢙࢔࢖ି૚ ൅ ࢼ࣓࢔૛࢙࢔࢖ି૛ ൅ ڮ ൅ ࣓࢔࢖࢔  
7) The root of H(s) must be real and negative. 
8) The smallest root of H(s) will set the desired settling 
time by   the relationship: [4/ (smallest root)] and 
equal approximately to the desired settling time. 
 
 Then increase K until the response becomes deadbeat and 
the settling time is approximately equal to the desired value. 
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Fig. 3 Robust deadbeat control structure 
 
TABLE I 
DEADBEAT COEFFICIENTS AND RESPONSE TIMES 
 
Order 
ሺ݊௣) 
ߙ ߚ ߛ ߜ ܶݎଽ଴ᇱ ௦ܶᇱ 
2nd 1.82    3.47 4.82
3rd 1.90 2.20   3.48 4.04
4th 2.20 3.50 2.80  4.16 4.81
5th 2.70 4.90 5.40 3.40 4.48 5.43
 
 
The design procedure of a PID-based robust deadbeat control, 
taking fourth-order F1(s) and fifth-order F2(s) systems as 
examples 
ܨଵሺݏ) ൌ
߱௡ସ
ݏସ ൅ ߙ߱௡ݏଷ ൅ ߚ߱௡ଶݏଶ ൅ ߛ߱௡ଷݏ ൅ ߱௡ସ                      ሺ10) 
 
and  
ܨଶሺݏ) ൌ
߱௡ହ
ݏହ ൅ ߙ߱௡ݏସ ൅ ߚ߱௡ଶݏଷ ൅ ߛ߱௡ଷݏଶ ൅ ߜ߱௡ସݏ ൅ ߱௡ହ    ሺ11) 
 
 For equations (10) and (11), the coefficients α, β, γ and δ 
are selected from Table 1. Taking the fourth-order system first 
as an example and then using the same procedure with fifth-
order system with a desired settling time 0.95 s, from Table 1 
the normalized settling time can be found as: 
 
௦ܶ ൌ
4.81
߱௡  
Therefore ω୬ can be found as: 
௦ܶ ൌ
4.81
0.95 ൌ 5.0632 
 The characteristic equation of the closed-loop transfer 
function of the forth-order systems is: 
 
ݏସ ൅ ߙ߱௡ݏଷ ൅ ߚ߱௡ଶݏଶ ൅ ߛ߱௡ଷݏ ൅ ߱௡ସ 
 
From Table I, α, β and γ can be found as: 
 
ߙ ൌ 2.20;  ߚ ൌ 3.50;  ߛ ൌ 2.80 
 
The transfer function of the forth-order systems is: 
 
ܨଵሺݏ) ൌ
657.183399
ݏସ ൅ 11.139ݏଷ ൅ 89.72448ݏଶ ൅ 363.4314ݏ ൅ 657.183399  ሺ12) 
 
 To apply the deadbeat technique to DoA model, first 
comparing the characteristic equation in equation (12), with 
the characteristic equations different patients. 
 
A. DoA Controller Design 
 
 The block diagram of the DoA designed system is 
depicted in Fig. 4. 
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Fig. 4 Robust deadbeat control structure for DoA 
 
ܩଵሺݏ) ൌ ܭܩ௖ሺݏ) ൌ
ܭሾܭ௖ሺݏଶ ൅ ܺݏ ൅ ܻ)ሿ
ݏ  
 
ܩଶሺݏ) ൌ
0.040382ሺs ൅ 0.025992)ሺs ൅ 0.0018266)
ሺs ൅ 0.37891)ሺs ൅ 0.005896)ሺs ൅ 0.0012622) 
 
ܪଵሺݏ) ൌ ሺ1 ൅ ܭ௕ݏ) 
 
ܪଶሺݏ) ൌ ܭ௔ 
 The closed-loop control function for DoA model can now 
be written as: 
 
ܥሺݏ)
ܴሺݏ) ൌ
Gଵሺs)Gଶሺs)
1 ൅ Gଶሺs)Hଶሺs) ൅ Gଵሺs)Gଶሺs)Hଵሺs) 
 
 Then, using the technique initially proposed by Dorf et al. 
in 1994 [5], to determine these parameters.  The characteristic 
equation of the above transfer faction is equal to the 
characteristic equation of the deadbeat transfer function. By 
using the characteristic equation of the deadbeat transfer 
function to obtain the characteristic equation of the closed-
loop transfer function of DoA as:   
 
ݏସ ൅ ߙ߱௡ݏଷ ൅ ߚ߱௡ଶݏଶ ൅ ߛ߱௡ଷݏ ൅ ߱௡ସ 
 
ߙ ൌ 2.20;  ߚ ൌ 3.50;  ߛ ൌ 2.80 
 
߱௡ ൌ ௦ܶ
ᇱ
80% ݋݂ ݐ݄݁ ݀݁ݏ݅ݎ݁݀ ݏ݁ݐݐ݈݅݊݃ ݐ݅݉݁ ௦ܶ  
 
  The desired settling time for DoA is 6 minutes, then ω୬ 
can be found as: 
߱௡ ൌ ௦ܶ
ᇱ
 ௦ܶ ൈ 80% ൌ
4.81
6 ൈ 60 ൈ 80% ൌ 0.0167 
 Therefore the characteristic equation now can be written 
as: 
ݏସ ൅ 0.03674ݏଷ ൅ 9.76115 ൈ 10ିସݏଶ ൅ 1.304 ൈ 10ିହݏ ൅ 7.7779 ൈ 10ି଼ 
Let K  equal to 1, and then by comparing the characteristic 
equation to find the variables as: 
ܭ௖ ൌ  1 ൈ 10ିସ ; ܭ௕ ൌ 1 ൈ 10ି଻ 
ܺ ൌ 363 ൈ 10ସ ;   ܻ ൌ 342.78 ൈ 10ସ;  ܭ௔ ൌ െ8.212 
 
Increase K until the response becomes deadbeat and settling 
time becomes approximately to the desired value.   
 
IV. SIMULATION AND RESULTS 
 The proposed control schemes were implemented and 
evaluated using Simulink and Matlab control toolbox to 
thoroughly investigate the system performance. 
Fig. 5 shows the diagram of implementation of the deadbeat 
DoA control system.  
 
 
Fig. 5 Implementation of a robust deadbeat control structure for DoA  
Fig. 6  DoA robust deadbeat control response for different values of K 
  
 Fig. 6 shows the responses of DoA system in different 
situations, in other words the value of K are changing from 1 
until the system reach better response, for example K equal 2, 
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2.5 and 7.23. It is clear that all the responses settle and reach 
the desired positions with the time frames. While, there are 
overshoot but the system responses still meet with all the 
requirements and specifications.  
 
 
Fig. 7 Comparison of the performance of the Deadbeat with, IMC and PID 
controllers 
 
 Fig. 7 shows the response of a traditional PID control for 
DoA. The parameters of PID controller for DoA are K୮ 
=1000, K୧= 10 and Kୢ=32. 
 
 
Fig. 8 DoA deadbeat control response for different patients 
 
Fig. 8 shows the response of the deadbeat control for DoA. 
Comparing Figs. 7 and 8, it is also clear that the robust control 
performance is much better that the IMC, where the settling 
time is approximately 8 minutes for IMC and  about 4.3 
minutes for  the robust deadbeat control. 
 
V. CONCLUSIONS 
 This study investigates a robust deadbeat control 
technique in DoA control. This technique was originally 
designed to suppress system parameters uncertainties. We 
applied this technique to accommodate the inter-patient 
differences for DoA control  
 The proposed method is implemented and evaluated in 
simulation using realistic data. The results are compared with 
the results obtained using two other methods. The 
comparisons show that the proposed robust deadbeat control 
scheme performs better both in overshoot/undershoot and 
settling time. The system settling time has been reduced to 1.5 
minutes and the over and undershoot also has been shorted 
about 15%.  
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